Clinical Trial Update: Neonatal CMV-Ganciclovir Follow-up Study

View source ↗

Summary

A completed follow-up clinical trial evaluating ganciclovir for neonatal cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infections | Status: COMPLETED